DualityBio

BiotechnologySeries BSuzhou, Chinadualitybiologics.com

Latest round

Series B

Last raised

May 2021

Total raised

$120M

Investors

9

About DualityBio

Founded in 2020 and based in Suzhou, China, Duality Biologics operates as a provider of innovative molecular drug that provides bispecific antibody drugs., BioNTech, etc. It has acquired FTD, ODD, IND and other certifications. The founder, chairman of the board and CEO, Zhu Zhongyuan, is a doctor of the University of Massachusetts Medical School, and has worked in Mingxin Capital, SIG Asia Investment Fund, etc.6 per share on the Hong Kong Stock Exchange. The company has developed DITAC, DIBAC, DIMAC, DUPAC and other technology platforms. Products include dual-antibody ADC, new mechanism-loaded ADC and autoimmune ADC. Its technologies and products can be used to treat cancer and autoimmune diseases. The company generates revenue by providing dual-antibody ADC, new mechanism-loaded ADC and autoimmune ADC.

Who invested in DualityBio

9 investors across 2 rounds

See all investors in DualityBio

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    May 20, 2021

    Amount

    $90M

    Investors

    Locked

  2. Series A

    Dec 31, 2020

    Amount

    $30M

    Investors

    Locked

Questions about DualityBio

Who invested in DualityBio?

DualityBio has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has DualityBio raised?

DualityBio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did DualityBio last raise money?

DualityBio's most recent round on record is a Series B, in May 2021.

What does DualityBio do?

Founded in 2020 and based in Suzhou, China, Duality Biologics operates as a provider of innovative molecular drug that provides bispecific antibody drugs.

Where is DualityBio headquartered?

DualityBio is headquartered in Suzhou, China.

Which VCs invest in companies like DualityBio?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at DualityBio's stage. Their profiles are linked below.

Raising like DualityBio? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.